Veena Lifesciences India Profile
Key Indicators
- Authorised Capital ₹ 9.90 Cr
as on 16-06-2024
- Paid Up Capital ₹ 9.79 Cr
as on 16-06-2024
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 8.80 Cr
as on 16-06-2024
- Revenue -2.05%
(FY 2022)
- Profit -64.09%
(FY 2022)
- Ebitda -205.94%
(FY 2022)
- Net Worth -49.31%
(FY 2022)
- Total Assets 4.97%
(FY 2022)
About Veena Lifesciences India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 9.90 Cr and a paid-up capital of Rs 9.79 Cr.
The company has closed loans amounting to ₹8.80 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Chinnapa Tera and Ravali Tera serve as directors at the Company.
- CIN/LLPIN
U24233TG2011PTC077370
- Company No.
077370
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2011
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Veena Lifesciences India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravali Tera  | Director | 30-Jun-2018 | Current |
Chinnapa Tera  | Director | 11-Nov-2011 | Current |
Financial Performance and Corporate Structure Insights of Veena Lifesciences India.
Veena Lifesciences India Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.05% decrease. The company also saw a substantial fall in profitability, with a 64.09% decrease in profit. The company's net worth observed a substantial decline by a decrease of 49.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Veena Lifesciences India?
In 2022, Veena Lifesciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Srini Pharmaceuticals Private LimitedActive 29 years 9 monthsChinnapa Tera and Ravali Tera are mutual person
- Laelia Resorts & Real Estates LlpActive 2 years 4 months
Chinnapa Tera and Ravali Tera are mutual person
- Tcr Resorts And Real Estates Private LimitedActive 7 years 16 days
Chinnapa Tera and Ravali Tera are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 30 Nov 2017 | ₹8.80 Cr | Satisfied |
How Many Employees Work at Veena Lifesciences India?
Veena Lifesciences India has a workforce of 15 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Veena Lifesciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Veena Lifesciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
